| UniProt ID | UBP7_HUMAN | |
|---|---|---|
| UniProt AC | Q93009 | |
| Protein Name | Ubiquitin carboxyl-terminal hydrolase 7 | |
| Gene Name | USP7 {ECO:0000312|HGNC:HGNC:12630} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1102 | |
| Subcellular Localization | Nucleus . Cytoplasm . Nucleus, PML body . Chromosome . Present in a minority of ND10 nuclear bodies. Association with ICP0/VMW110 at early times of infection leads to an increased proportion of USP7-containing ND10. Colocalizes with ATXN1 in the nucl | |
| Protein Description | Hydrolase that deubiquitinates target proteins such as FOXO4, p53/TP53, MDM2, ERCC6, DNMT1, UHRF1, PTEN, KMT2E/MLL5 and DAXX. [PubMed: 11923872] | |
| Protein Sequence | MNHQQQQQQQKAGEQQLSEPEDMEMEAGDTDDPPRITQNPVINGNVALSDGHNTAEEDMEDDTSWRSEATFQFTVERFSRLSESVLSPPCFVRNLPWKIMVMPRFYPDRPHQKSVGFFLQCNAESDSTSWSCHAQAVLKIINYRDDEKSFSRRISHLFFHKENDWGFSNFMAWSEVTDPEKGFIDDDKVTFEVFVQADAPHGVAWDSKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKRKERQEAHLYMQVQIVAEDQFCGHQGNDMYDEEKVKYTVFKVLKNSSLAEFVQSLSQTMGFPQDQIRLWPMQARSNGTKRPAMLDNEADGNKTMIELSDNENPWTIFLETVDPELAASGATLPKFDKDHDVMLFLKMYDPKTRSLNYCGHIYTPISCKIRDLLPVMCDRAGFIQDTSLILYEEVKPNLTERIQDYDVSLDKALDELMDGDIIVFQKDDPENDNSELPTAKEYFRDLYHRVDVIFCDKTIPNDPGFVVTLSNRMNYFQVAKTVAQRLNTDPMLLQFFKSQGYRDGPGNPLRHNYEGTLRDLLQFFKPRQPKKLYYQQLKMKITDFENRRSFKCIWLNSQFREEEITLYPDKHGCVRDLLEECKKAVELGEKASGKLRLLEIVSYKIIGVHQEDELLECLSPATSRTFRIEEIPLDQVDIDKENEMLVTVAHFHKEVFGTFGIPFLLRIHQGEHFREVMKRIQSLLDIQEKEFEKFKFAIVMMGRHQYINEDEYEVNLKDFEPQPGNMSHPRPWLGLDHFNKAPKRSRYTYLEKAIKIHN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 18 | Phosphorylation | KAGEQQLSEPEDMEM HHHHHHCCCHHHCCC | 46.93 | 29255136 | |
| 30 | Phosphorylation | MEMEAGDTDDPPRIT CCCCCCCCCCCCCCC | 41.19 | 23927012 | |
| 37 | Phosphorylation | TDDPPRITQNPVING CCCCCCCCCCCEECC | 24.47 | 30576142 | |
| 49 | Phosphorylation | INGNVALSDGHNTAE ECCCEEECCCCCCCC | 31.63 | 28348404 | |
| 54 | Phosphorylation | ALSDGHNTAEEDMED EECCCCCCCCHHCCC | 29.76 | 28348404 | |
| 63 | Phosphorylation | EEDMEDDTSWRSEAT CHHCCCCCCCCCCEE | 42.38 | 29978859 | |
| 64 | Phosphorylation | EDMEDDTSWRSEATF HHCCCCCCCCCCEEE | 27.73 | 29978859 | |
| 79 | Phosphorylation | QFTVERFSRLSESVL EEEHHHHHHHCHHCC | 38.23 | 28348404 | |
| 82 | Ubiquitination | VERFSRLSESVLSPP HHHHHHHCHHCCCCC | 27.07 | 21890473 | |
| 82 | Phosphorylation | VERFSRLSESVLSPP HHHHHHHCHHCCCCC | 27.07 | 24719451 | |
| 84 | Phosphorylation | RFSRLSESVLSPPCF HHHHHCHHCCCCCEE | 25.61 | 28348404 | |
| 98 | Ubiquitination | FVRNLPWKIMVMPRF EECCCCEEEEEECCC | 20.98 | 21906983 | |
| 106 | Phosphorylation | IMVMPRFYPDRPHQK EEEECCCCCCCCCCC | 12.90 | 28152594 | |
| 132 | Ubiquitination | SDSTSWSCHAQAVLK CCCCCCEEEHHHHHH | 2.22 | 21890473 | |
| 143 | Phosphorylation | AVLKIINYRDDEKSF HHHHHHCCCCCCCCH | 12.66 | 28152594 | |
| 148 | Ubiquitination | INYRDDEKSFSRRIS HCCCCCCCCHHHHHH | 64.89 | 21906983 | |
| 149 | Phosphorylation | NYRDDEKSFSRRISH CCCCCCCCHHHHHHH | 26.80 | 23882029 | |
| 151 | Phosphorylation | RDDEKSFSRRISHLF CCCCCCHHHHHHHHH | 27.95 | 17081983 | |
| 155 | Phosphorylation | KSFSRRISHLFFHKE CCHHHHHHHHHHCCC | 16.60 | 23882029 | |
| 209 | Ubiquitination | GVAWDSKKHTGYVGL CEEECCCCCCCCCCC | 50.80 | - | |
| 211 | Phosphorylation | AWDSKKHTGYVGLKN EECCCCCCCCCCCCC | 38.80 | 28152594 | |
| 213 | Phosphorylation | DSKKHTGYVGLKNQG CCCCCCCCCCCCCCC | 7.78 | 28152594 | |
| 224 | Ubiquitination | KNQGATCYMNSLLQT CCCCCCCHHHHHHHH | 8.58 | - | |
| 238 | Ubiquitination | TLFFTNQLRKAVYMM HHHHHHHHHHEEEEC | 7.04 | 21890473 | |
| 240 | Ubiquitination | FFTNQLRKAVYMMPT HHHHHHHHEEEECCC | 51.28 | - | |
| 254 | Acetylation | TEGDDSSKSVPLALQ CCCCCCCCCHHHHHH | 60.47 | 26051181 | |
| 254 | Ubiquitination | TEGDDSSKSVPLALQ CCCCCCCCCHHHHHH | 60.47 | 21906983 | |
| 256 | Acetylation | GDDSSKSVPLALQRV CCCCCCCHHHHHHHH | 5.31 | - | |
| 256 | Ubiquitination | GDDSSKSVPLALQRV CCCCCCCHHHHHHHH | 5.31 | - | |
| 272 | Acetylation | YELQHSDKPVGTKKL HHHHCCCCCCCCCCH | 44.62 | 23954790 | |
| 272 | Malonylation | YELQHSDKPVGTKKL HHHHCCCCCCCCCCH | 44.62 | 26320211 | |
| 272 | Ubiquitination | YELQHSDKPVGTKKL HHHHCCCCCCCCCCH | 44.62 | - | |
| 277 | 2-Hydroxyisobutyrylation | SDKPVGTKKLTKSFG CCCCCCCCCHHHHHC | 39.60 | - | |
| 277 | Acetylation | SDKPVGTKKLTKSFG CCCCCCCCCHHHHHC | 39.60 | 25953088 | |
| 281 | Acetylation | VGTKKLTKSFGWETL CCCCCHHHHHCHHHH | 54.98 | 26051181 | |
| 296 | Ubiquitination | DSFMQHDVQELCRVL HHHHHHCHHHHHHHH | 4.46 | - | |
| 310 | 2-Hydroxyisobutyrylation | LLDNVENKMKGTCVE HHHCCCHHCCCCCEE | 28.60 | - | |
| 310 | Acetylation | LLDNVENKMKGTCVE HHHCCCHHCCCCCEE | 28.60 | 25953088 | |
| 312 | Acetylation | DNVENKMKGTCVEGT HCCCHHCCCCCEECC | 53.32 | 26051181 | |
| 312 | Ubiquitination | DNVENKMKGTCVEGT HCCCHHCCCCCEECC | 53.32 | - | |
| 319 | Ubiquitination | KGTCVEGTIPKLFRG CCCCEECCHHHHHCC | 22.17 | - | |
| 322 | Acetylation | CVEGTIPKLFRGKMV CEECCHHHHHCCCEE | 57.30 | 25953088 | |
| 322 | Ubiquitination | CVEGTIPKLFRGKMV CEECCHHHHHCCCEE | 57.30 | - | |
| 327 | 2-Hydroxyisobutyrylation | IPKLFRGKMVSYIQC HHHHHCCCEEEEEEE | 31.69 | - | |
| 327 | Acetylation | IPKLFRGKMVSYIQC HHHHHCCCEEEEEEE | 31.69 | 25953088 | |
| 327 | Malonylation | IPKLFRGKMVSYIQC HHHHHCCCEEEEEEE | 31.69 | 26320211 | |
| 331 | Phosphorylation | FRGKMVSYIQCKEVD HCCCEEEEEEEEECC | 5.43 | - | |
| 335 | Ubiquitination | MVSYIQCKEVDYRSD EEEEEEEEECCCCCC | 44.38 | - | |
| 339 | Ubiquitination | IQCKEVDYRSDRRED EEEEECCCCCCCCCC | 19.72 | 21890473 | |
| 355 | Ubiquitination | YDIQLSIKGKKNIFE EEEEEEECCCCCHHH | 62.39 | 21906983 | |
| 357 | Ubiquitination | IQLSIKGKKNIFESF EEEEECCCCCHHHHH | 37.33 | - | |
| 358 | Acetylation | QLSIKGKKNIFESFV EEEECCCCCHHHHHC | 65.04 | 26051181 | |
| 358 | Ubiquitination | QLSIKGKKNIFESFV EEEECCCCCHHHHHC | 65.04 | - | |
| 379 | Phosphorylation | QLDGDNKYDAGEHGL ECCCCCCCCCCHHHH | 19.78 | - | |
| 391 | 2-Hydroxyisobutyrylation | HGLQEAEKGVKFLTL HHHHHHHHCCCEEEC | 75.86 | - | |
| 391 | Ubiquitination | HGLQEAEKGVKFLTL HHHHHHHHCCCEEEC | 75.86 | - | |
| 404 | Ubiquitination | TLPPVLHLQLMRFMY ECCCHHHHHHHHHHH | 3.51 | 21890473 | |
| 420 | Ubiquitination | PQTDQNIKINDRFEF CCCCCCCEECCCCCC | 42.90 | 21906983 | |
| 423 | Ubiquitination | DQNIKINDRFEFPEQ CCCCEECCCCCCCCC | 61.18 | 21890473 | |
| 424 | Methylation | QNIKINDRFEFPEQL CCCEECCCCCCCCCC | 28.62 | 115919673 | |
| 439 | Ubiquitination | PLDEFLQKTDPKDPA CHHHHHHHCCCCCHH | 57.98 | 21906983 | |
| 460 | Ubiquitination | VLVHSGDNHGGHYVV EEEECCCCCCCEEEE | 38.95 | - | |
| 463 | Ubiquitination | HSGDNHGGHYVVYLN ECCCCCCCEEEEEEC | 11.03 | 21890473 | |
| 474 | Ubiquitination | VYLNPKGDGKWCKFD EEECCCCCCCCCCCC | 62.72 | - | |
| 476 | Acetylation | LNPKGDGKWCKFDDD ECCCCCCCCCCCCHH | 54.91 | 26051181 | |
| 476 | Ubiquitination | LNPKGDGKWCKFDDD ECCCCCCCCCCCCHH | 54.91 | - | |
| 479 | Acetylation | KGDGKWCKFDDDVVS CCCCCCCCCCHHHHH | 51.19 | 25953088 | |
| 479 | Ubiquitination | KGDGKWCKFDDDVVS CCCCCCCCCCHHHHH | 51.19 | 21906983 | |
| 490 | Acetylation | DVVSRCTKEEAIEHN HHHHHCCHHHHHHHC | 58.12 | 26051181 | |
| 490 | Ubiquitination | DVVSRCTKEEAIEHN HHHHHCCHHHHHHHC | 58.12 | - | |
| 507 | Ubiquitination | GHDDDLSVRHCTNAY CCCCCCHHHHHCCEE | 6.69 | - | |
| 523 | Ubiquitination | LVYIRESKLSEVLQA EEEEEHHHHHHHHHH | 51.81 | - | |
| 579 | Ubiquitination | EDQFCGHQGNDMYDE CCCCCCCCCCCCCCH | 37.35 | - | |
| 595 | Acetylation | KVKYTVFKVLKNSSL HHHHHHHHHHCCCCH | 42.18 | 19608861 | |
| 595 | Ubiquitination | KVKYTVFKVLKNSSL HHHHHHHHHHCCCCH | 42.18 | 19608861 | |
| 665 | Ubiquitination | WTIFLETVDPELAAS EEEEEEECCHHHHHC | 9.37 | - | |
| 672 | Phosphorylation | VDPELAASGATLPKF CCHHHHHCCCCCCCC | 24.29 | 21406692 | |
| 675 | Phosphorylation | ELAASGATLPKFDKD HHHHCCCCCCCCCCC | 47.31 | 21406692 | |
| 679 | Ubiquitination | SGATLPKFDKDHDVM CCCCCCCCCCCCCEE | 15.49 | - | |
| 681 | 2-Hydroxyisobutyrylation | ATLPKFDKDHDVMLF CCCCCCCCCCCEEEE | 61.16 | - | |
| 681 | Acetylation | ATLPKFDKDHDVMLF CCCCCCCCCCCEEEE | 61.16 | 26051181 | |
| 681 | Ubiquitination | ATLPKFDKDHDVMLF CCCCCCCCCCCEEEE | 61.16 | - | |
| 695 | Ubiquitination | FLKMYDPKTRSLNYC EEEECCCCCCCCCCC | 54.39 | - | |
| 696 | Ubiquitination | LKMYDPKTRSLNYCG EEECCCCCCCCCCCC | 30.77 | - | |
| 701 | Phosphorylation | PKTRSLNYCGHIYTP CCCCCCCCCCCEECC | 12.71 | 28152594 | |
| 706 | Phosphorylation | LNYCGHIYTPISCKI CCCCCCEECCCCCCH | 10.78 | 28152594 | |
| 707 | Phosphorylation | NYCGHIYTPISCKIR CCCCCEECCCCCCHH | 17.34 | 28152594 | |
| 710 | Phosphorylation | GHIYTPISCKIRDLL CCEECCCCCCHHHHH | 15.57 | 28152594 | |
| 712 | Ubiquitination | IYTPISCKIRDLLPV EECCCCCCHHHHHHH | 33.70 | - | |
| 730 | Phosphorylation | RAGFIQDTSLILYEE CCCCCCCCCEEEEEE | 14.73 | 27251275 | |
| 731 | Phosphorylation | AGFIQDTSLILYEEV CCCCCCCCEEEEEEC | 23.00 | 28348404 | |
| 735 | Phosphorylation | QDTSLILYEEVKPNL CCCCEEEEEECCCCH | 11.75 | 27273156 | |
| 739 | Sumoylation | LILYEEVKPNLTERI EEEEEECCCCHHHHH | 31.31 | - | |
| 743 | Phosphorylation | EEVKPNLTERIQDYD EECCCCHHHHHHHCC | 29.83 | - | |
| 749 | Phosphorylation | LTERIQDYDVSLDKA HHHHHHHCCCCHHHH | 11.23 | 27642862 | |
| 752 | Phosphorylation | RIQDYDVSLDKALDE HHHHCCCCHHHHHHH | 28.14 | 20873877 | |
| 755 | Ubiquitination | DYDVSLDKALDELMD HCCCCHHHHHHHHCC | 57.02 | - | |
| 761 | Sulfoxidation | DKALDELMDGDIIVF HHHHHHHCCCCEEEE | 5.21 | 21406390 | |
| 770 | Ubiquitination | GDIIVFQKDDPENDN CCEEEEECCCCCCCC | 53.27 | - | |
| 782 | Phosphorylation | NDNSELPTAKEYFRD CCCCCCCCHHHHHHH | 64.09 | 24719451 | |
| 784 | Ubiquitination | NSELPTAKEYFRDLY CCCCCCHHHHHHHHH | 56.26 | - | |
| 791 | Phosphorylation | KEYFRDLYHRVDVIF HHHHHHHHHHCCEEE | 7.59 | 28152594 | |
| 801 | Acetylation | VDVIFCDKTIPNDPG CCEEEECCCCCCCCC | 49.92 | 26051181 | |
| 802 | O-linked_Glycosylation | DVIFCDKTIPNDPGF CEEEECCCCCCCCCE | 28.54 | 23301498 | |
| 808 | Ubiquitination | KTIPNDPGFVVTLSN CCCCCCCCEEEEECC | 30.74 | 21890473 | |
| 824 | Acetylation | MNYFQVAKTVAQRLN CCHHHHHHHHHHHHC | 44.68 | 25953088 | |
| 824 | Ubiquitination | MNYFQVAKTVAQRLN CCHHHHHHHHHHHHC | 44.68 | 21906983 | |
| 825 | Ubiquitination | NYFQVAKTVAQRLNT CHHHHHHHHHHHHCC | 16.01 | 21890473 | |
| 832 | Phosphorylation | TVAQRLNTDPMLLQF HHHHHHCCCHHHHHH | 46.18 | 27174698 | |
| 835 | Sulfoxidation | QRLNTDPMLLQFFKS HHHCCCHHHHHHHHH | 6.94 | 21406390 | |
| 841 | Acetylation | PMLLQFFKSQGYRDG HHHHHHHHHCCCCCC | 43.06 | 25953088 | |
| 841 | Methylation | PMLLQFFKSQGYRDG HHHHHHHHHCCCCCC | 43.06 | 66726983 | |
| 841 | Ubiquitination | PMLLQFFKSQGYRDG HHHHHHHHHCCCCCC | 43.06 | 21906983 | |
| 842 | Phosphorylation | MLLQFFKSQGYRDGP HHHHHHHHCCCCCCC | 24.55 | 27174698 | |
| 845 | Phosphorylation | QFFKSQGYRDGPGNP HHHHHCCCCCCCCCC | 9.63 | 28152594 | |
| 853 | Acetylation | RDGPGNPLRHNYEGT CCCCCCCCCCCCCCH | 11.45 | - | |
| 853 | Ubiquitination | RDGPGNPLRHNYEGT CCCCCCCCCCCCCCH | 11.45 | 21890473 | |
| 859 | Ubiquitination | PLRHNYEGTLRDLLQ CCCCCCCCHHHHHHH | 21.49 | - | |
| 866 | Ubiquitination | GTLRDLLQFFKPRQP CHHHHHHHHHCCCCC | 49.37 | 21890473 | |
| 869 | Acetylation | RDLLQFFKPRQPKKL HHHHHHHCCCCCCCH | 40.35 | 19608861 | |
| 869 | Sumoylation | RDLLQFFKPRQPKKL HHHHHHHCCCCCCCH | 40.35 | 28112733 | |
| 869 | Ubiquitination | RDLLQFFKPRQPKKL HHHHHHHCCCCCCCH | 40.35 | 21906983 | |
| 875 | Ubiquitination | FKPRQPKKLYYQQLK HCCCCCCCHHHHHHH | 48.70 | 21906983 | |
| 877 | Phosphorylation | PRQPKKLYYQQLKMK CCCCCCHHHHHHHHH | 14.22 | 30576142 | |
| 878 | Phosphorylation | RQPKKLYYQQLKMKI CCCCCHHHHHHHHHC | 10.54 | 30576142 | |
| 882 | Sumoylation | KLYYQQLKMKITDFE CHHHHHHHHHCCCCC | 33.53 | 28112733 | |
| 882 | Ubiquitination | KLYYQQLKMKITDFE CHHHHHHHHHCCCCC | 33.53 | 21906983 | |
| 884 | Ubiquitination | YYQQLKMKITDFENR HHHHHHHHCCCCCCC | 40.65 | - | |
| 886 | Phosphorylation | QQLKMKITDFENRRS HHHHHHCCCCCCCCC | 29.17 | 30576142 | |
| 891 | Methylation | KITDFENRRSFKCIW HCCCCCCCCCEEEEE | 28.55 | 115919677 | |
| 893 | Phosphorylation | TDFENRRSFKCIWLN CCCCCCCCEEEEEEC | 26.31 | 27067055 | |
| 895 | Acetylation | FENRRSFKCIWLNSQ CCCCCCEEEEEECCC | 26.51 | 26051181 | |
| 898 | Acetylation | RRSFKCIWLNSQFRE CCCEEEEEECCCCCC | 10.04 | - | |
| 898 | Ubiquitination | RRSFKCIWLNSQFRE CCCEEEEEECCCCCC | 10.04 | - | |
| 910 | Ubiquitination | FREEEITLYPDKHGC CCCEEECCCCCCCCH | 7.79 | - | |
| 911 | Ubiquitination | REEEITLYPDKHGCV CCEEECCCCCCCCHH | 10.75 | - | |
| 914 | 2-Hydroxyisobutyrylation | EITLYPDKHGCVRDL EECCCCCCCCHHHHH | 37.08 | - | |
| 914 | Acetylation | EITLYPDKHGCVRDL EECCCCCCCCHHHHH | 37.08 | 23749302 | |
| 914 | Ubiquitination | EITLYPDKHGCVRDL EECCCCCCCCHHHHH | 37.08 | - | |
| 918 | Acetylation | YPDKHGCVRDLLEEC CCCCCCHHHHHHHHH | 6.72 | - | |
| 918 | Ubiquitination | YPDKHGCVRDLLEEC CCCCCCHHHHHHHHH | 6.72 | - | |
| 926 | Acetylation | RDLLEECKKAVELGE HHHHHHHHHHHHHHH | 47.23 | 26051181 | |
| 926 | Ubiquitination | RDLLEECKKAVELGE HHHHHHHHHHHHHHH | 47.23 | - | |
| 927 | Ubiquitination | DLLEECKKAVELGEK HHHHHHHHHHHHHHH | 70.13 | - | |
| 934 | Acetylation | KAVELGEKASGKLRL HHHHHHHHHCCCCHH | 46.16 | 23749302 | |
| 934 | Ubiquitination | KAVELGEKASGKLRL HHHHHHHHHCCCCHH | 46.16 | 21906983 | |
| 946 | Phosphorylation | LRLLEIVSYKIIGVH CHHHHHEEEEEEEEC | 26.77 | 20860994 | |
| 963 | Phosphorylation | DELLECLSPATSRTF HHHHHHCCCCCCCEE | 24.93 | 30266825 | |
| 966 | Phosphorylation | LECLSPATSRTFRIE HHHCCCCCCCEEEEE | 23.33 | 30266825 | |
| 967 | Phosphorylation | ECLSPATSRTFRIEE HHCCCCCCCEEEEEE | 31.28 | 30266825 | |
| 1017 | Ubiquitination | RIHQGEHFREVMKRI EHHCCHHHHHHHHHH | 6.57 | 21890473 | |
| 1023 | Ubiquitination | HFREVMKRIQSLLDI HHHHHHHHHHHHHHH | 17.68 | - | |
| 1026 | Phosphorylation | EVMKRIQSLLDIQEK HHHHHHHHHHHHCHH | 28.64 | 27050516 | |
| 1033 | Acetylation | SLLDIQEKEFEKFKF HHHHHCHHHHHHHHE | 51.86 | 25953088 | |
| 1033 | Ubiquitination | SLLDIQEKEFEKFKF HHHHHCHHHHHHHHE | 51.86 | 21906983 | |
| 1037 | Acetylation | IQEKEFEKFKFAIVM HCHHHHHHHHEEEEE | 60.21 | 25953088 | |
| 1039 | Ubiquitination | EKEFEKFKFAIVMMG HHHHHHHHEEEEECC | 44.98 | - | |
| 1050 | Phosphorylation | VMMGRHQYINEDEYE EECCCCCCCCCCCEE | 10.29 | - | |
| 1056 | Phosphorylation | QYINEDEYEVNLKDF CCCCCCCEEEECCCC | 37.18 | - | |
| 1068 | Acetylation | KDFEPQPGNMSHPRP CCCCCCCCCCCCCCC | 36.91 | - | |
| 1080 | Ubiquitination | PRPWLGLDHFNKAPK CCCCCCCCCCCCCCC | 42.40 | 21890473 | |
| 1084 | Acetylation | LGLDHFNKAPKRSRY CCCCCCCCCCCCHHH | 66.19 | 19608861 | |
| 1084 | Malonylation | LGLDHFNKAPKRSRY CCCCCCCCCCCCHHH | 66.19 | 26320211 | |
| 1084 | Ubiquitination | LGLDHFNKAPKRSRY CCCCCCCCCCCCHHH | 66.19 | 19608861 | |
| 1089 | Phosphorylation | FNKAPKRSRYTYLEK CCCCCCCHHHHHHHH | 35.45 | 24719451 | |
| 1091 | Phosphorylation | KAPKRSRYTYLEKAI CCCCCHHHHHHHHHH | 10.86 | 23312004 | |
| 1092 | Phosphorylation | APKRSRYTYLEKAIK CCCCHHHHHHHHHHH | 22.11 | 23312004 | |
| 1093 | Phosphorylation | PKRSRYTYLEKAIKI CCCHHHHHHHHHHHC | 12.15 | 23312004 | |
| 1096 | Acetylation | SRYTYLEKAIKIHN- HHHHHHHHHHHCCC- | 53.46 | 19608861 | |
| 1096 | Ubiquitination | SRYTYLEKAIKIHN- HHHHHHHHHHHCCC- | 53.46 | 21906983 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBP7_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-595; LYS-869; LYS-1084 ANDLYS-1096, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18; SER-49 AND THR-54,AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND SER-963, AND MASSSPECTROMETRY. | |
| "Biochemical characterization of USP7 reveals post-translationalmodification sites and structural requirements for substrateprocessing and subcellular localization."; Fernandez-Montalvan A., Bouwmeester T., Joberty G., Mader R.,Mahnke M., Pierrat B., Schlaeppi J.M., Worpenberg S., Gerhartz B.; FEBS J. 274:4256-4270(2007). Cited for: SUBUNIT, PHOSPHORYLATION AT SER-18 AND SER-963, UBIQUITINATION ATLYS-869, SUBCELLULAR LOCATION, AND MASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. | |
| Ubiquitylation | |
| Reference | PubMed |
| "Biochemical characterization of USP7 reveals post-translationalmodification sites and structural requirements for substrateprocessing and subcellular localization."; Fernandez-Montalvan A., Bouwmeester T., Joberty G., Mader R.,Mahnke M., Pierrat B., Schlaeppi J.M., Worpenberg S., Gerhartz B.; FEBS J. 274:4256-4270(2007). Cited for: SUBUNIT, PHOSPHORYLATION AT SER-18 AND SER-963, UBIQUITINATION ATLYS-869, SUBCELLULAR LOCATION, AND MASS SPECTROMETRY. | |